Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Pharmac won't drop low-ranked medicines from its funding list after public outcry over equity and access concerns.
Pharmac has scrapped plans to remove low-ranked medicines from its Options for Investment list after widespread opposition from patients, advocates, and communities.
Concerns centered on equity, particularly for Māori, Pacific peoples, rural populations, and those with rare disorders, as well as the importance of maintaining hope for future funding.
The agency confirmed it will not implement the change, emphasizing its ongoing commitment to transparency and timeliness through its Reset Programme.
Public input will continue to shape future decisions.
3 Articles
Pharmac no eliminará medicamentos de bajo rango de su lista de financiamiento después de la protesta pública sobre la equidad y las preocupaciones de acceso.